222 related articles for article (PubMed ID: 27460974)
1. Different promoter affinities account for specificity in MYC-dependent gene regulation.
Lorenzin F; Benary U; Baluapuri A; Walz S; Jung LA; von Eyss B; Kisker C; Wolf J; Eilers M; Wolf E
Elife; 2016 Jul; 5():. PubMed ID: 27460974
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide analysis of c-MYC-regulated mRNAs and miRNAs, and c-MYC DNA binding by next-generation sequencing.
Jackstadt R; Menssen A; Hermeking H
Methods Mol Biol; 2013; 1012():145-85. PubMed ID: 24006064
[TBL] [Abstract][Full Text] [Related]
3. Tuning the MYC response.
Zheng Y; Levens D
Elife; 2016 Jul; 5():. PubMed ID: 27460973
[TBL] [Abstract][Full Text] [Related]
4. Genomic targets of the human c-Myc protein.
Fernandez PC; Frank SR; Wang L; Schroeder M; Liu S; Greene J; Cocito A; Amati B
Genes Dev; 2003 May; 17(9):1115-29. PubMed ID: 12695333
[TBL] [Abstract][Full Text] [Related]
5. The mouse C/EBPdelta gene promoter is regulated by STAT3 and Sp1 transcriptional activators, chromatin remodeling and c-Myc repression.
Zhang Y; Sif S; DeWille J
J Cell Biochem; 2007 Dec; 102(5):1256-70. PubMed ID: 17471507
[TBL] [Abstract][Full Text] [Related]
6. WDR5 Supports an N-Myc Transcriptional Complex That Drives a Protumorigenic Gene Expression Signature in Neuroblastoma.
Sun Y; Bell JL; Carter D; Gherardi S; Poulos RC; Milazzo G; Wong JW; Al-Awar R; Tee AE; Liu PY; Liu B; Atmadibrata B; Wong M; Trahair T; Zhao Q; Shohet JM; Haupt Y; Schulte JH; Brown PJ; Arrowsmith CH; Vedadi M; MacKenzie KL; Hüttelmaier S; Perini G; Marshall GM; Braithwaite A; Liu T
Cancer Res; 2015 Dec; 75(23):5143-54. PubMed ID: 26471359
[TBL] [Abstract][Full Text] [Related]
7. Transcription factor binding and induced transcription alter chromosomal c-myc replicator activity.
Ghosh M; Liu G; Randall G; Bevington J; Leffak M
Mol Cell Biol; 2004 Dec; 24(23):10193-207. PubMed ID: 15542830
[TBL] [Abstract][Full Text] [Related]
8. Global mapping of c-Myc binding sites and target gene networks in human B cells.
Zeller KI; Zhao X; Lee CW; Chiu KP; Yao F; Yustein JT; Ooi HS; Orlov YL; Shahab A; Yong HC; Fu Y; Weng Z; Kuznetsov VA; Sung WK; Ruan Y; Dang CV; Wei CL
Proc Natl Acad Sci U S A; 2006 Nov; 103(47):17834-9. PubMed ID: 17093053
[TBL] [Abstract][Full Text] [Related]
9. Genome-Wide Analysis of c-MYC-Regulated mRNAs and miRNAs and c-MYC DNA-Binding by Next-Generation Sequencing.
Jackstadt R; Kaller M; Menssen A; Hermeking H
Methods Mol Biol; 2021; 2318():119-160. PubMed ID: 34019289
[TBL] [Abstract][Full Text] [Related]
10. MINCR is a MYC-induced lncRNA able to modulate MYC's transcriptional network in Burkitt lymphoma cells.
Doose G; Haake A; Bernhart SH; López C; Duggimpudi S; Wojciech F; Bergmann AK; Borkhardt A; Burkhardt B; Claviez A; Dimitrova L; Haas S; Hoell JI; Hummel M; Karsch D; Klapper W; Kleo K; Kretzmer H; Kreuz M; Küppers R; Lawerenz C; Lenze D; Loeffler M; Mantovani-Löffler L; Möller P; Ott G; Richter J; Rohde M; Rosenstiel P; Rosenwald A; Schilhabel M; Schneider M; Scholz I; Stilgenbauer S; Stunnenberg HG; Szczepanowski M; Trümper L; Weniger MA; ; Hoffmann S; Siebert R; Iaccarino I
Proc Natl Acad Sci U S A; 2015 Sep; 112(38):E5261-70. PubMed ID: 26351698
[TBL] [Abstract][Full Text] [Related]
11. Dual control of myc expression through a single DNA binding site targeted by ets family proteins and E2F-1.
Roussel MF; Davis JN; Cleveland JL; Ghysdael J; Hiebert SW
Oncogene; 1994 Feb; 9(2):405-15. PubMed ID: 8290253
[TBL] [Abstract][Full Text] [Related]
12. Evidence for a cancer-specific switch at the CDK4 promoter with loss of control by both USF and c-Myc.
Pawar SA; Szentirmay MN; Hermeking H; Sawadogo M
Oncogene; 2004 Aug; 23(36):6125-35. PubMed ID: 15208653
[TBL] [Abstract][Full Text] [Related]
13. p53-Dependent transcriptional repression of c-myc is required for G1 cell cycle arrest.
Ho JS; Ma W; Mao DY; Benchimol S
Mol Cell Biol; 2005 Sep; 25(17):7423-31. PubMed ID: 16107691
[TBL] [Abstract][Full Text] [Related]
14. c-Myc creates an activation loop by transcriptionally repressing its own functional inhibitor, hMad4, in young fibroblasts, a loop lost in replicatively senescent fibroblasts.
Marcotte R; Chen JM; Huard S; Wang E
J Cell Biochem; 2005 Dec; 96(5):1071-85. PubMed ID: 16167342
[TBL] [Abstract][Full Text] [Related]
15. Analysis of c-Myc and Max binding to the c-myc promoter: evidence that autosuppression occurs via an indirect mechanism.
Buckle RS; Méchali M
Oncogene; 1995 Mar; 10(6):1249-55. PubMed ID: 7700652
[TBL] [Abstract][Full Text] [Related]
16. In vivo transcriptional regulation of N-Myc target genes is controlled by E-box methylation.
Perini G; Diolaiti D; Porro A; Della Valle G
Proc Natl Acad Sci U S A; 2005 Aug; 102(34):12117-22. PubMed ID: 16093321
[TBL] [Abstract][Full Text] [Related]
17. Direct recruitment of N-myc to target gene promoters.
Mac SM; D'Cunha CA; Farnham PJ
Mol Carcinog; 2000 Oct; 29(2):76-86. PubMed ID: 11074604
[TBL] [Abstract][Full Text] [Related]
18. Myc-binding-site recognition in the human genome is determined by chromatin context.
Guccione E; Martinato F; Finocchiaro G; Luzi L; Tizzoni L; Dall' Olio V; Zardo G; Nervi C; Bernard L; Amati B
Nat Cell Biol; 2006 Jul; 8(7):764-70. PubMed ID: 16767079
[TBL] [Abstract][Full Text] [Related]
19. Histone deacetylase inhibitor, Trichostatin A, activates p21WAF1/CIP1 expression through downregulation of c-myc and release of the repression of c-myc from the promoter in human cervical cancer cells.
Li H; Wu X
Biochem Biophys Res Commun; 2004 Nov; 324(2):860-7. PubMed ID: 15474507
[TBL] [Abstract][Full Text] [Related]
20. Chromatin dynamics at the hTERT promoter during transcriptional activation and repression by c-Myc and Mnt in Xenopus leavis oocytes.
Wahlström T; Belikov S; Arsenian Henriksson M
Exp Cell Res; 2013 Dec; 319(20):3160-9. PubMed ID: 23860446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
